Nuclear factor-κB expression in the endometrium of normal and overweight women with polycystic ovary syndrome

References

• Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA. 2002. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biology of Reproduction 66:297–304.
   PubMed Web of Science ®Google Scholar
• Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, et al. 1986. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Research 46:5419–5425.
   PubMed Web of Science ®Google Scholar
• Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nature Reviews Molecular Cell Biology 5:392–401.
   PubMed Web of Science ®Google Scholar
• Celik O, Celik E, Turkcuoglu I, Yilmaz E, Ulas M, Simsek Y, et al. 2013. Surgical removal of endometrioma decreases the NF-κB1 (p50/105) and NF-κB p65 (Rel A) expression in the eutopic endometrium during the implantation window. Reproductive Sciences 20:762–770.
   PubMed Web of Science ®Google Scholar
• Celik O, Celik N, Hascalik S, Sahin I, Aydin S, Ozerol E. 2011. An appraisal of serum preptin levels in PCOS. Fertility and Sterility 95:314–316.
   PubMed Web of Science ®Google Scholar
• Cermik D, Selam B, Taylor HS. 2003. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 88:238–243.
   PubMed Web of Science ®Google Scholar
• Creus M, Ordi J, Fábregues F, Casamitjana R, Ferrer B, Coll E, et al. 2002. alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women. Human Reproduction 17:2279–2286.
   PubMed Web of Science ®Google Scholar
• Daftary GS, Kayisli U, Seli E, Bukulmez O, Arici A, Taylor HS. 2007. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertility and Sterility 87:367–372.
   PubMed Web of Science ®Google Scholar
• Donaghay M, Lessey BA. 2007. Uterine receptivity: alterations associated with benign gynecological disease. Seminars in Reproductive Medicine 25:461–475.
   PubMed Web of Science ®Google Scholar
• Dor J, Itzkowic DJ, Mashiach S, Lunenfeld B, Serr DM. 1980. Cumulative conception rates following gonadotropin therapy. American Journal of Obstetrics & Gynecology 136:102–105.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165–1174.
   PubMed Web of Science ®Google Scholar
• Ersahin A, Acet M, Acet T, Yavuz Y. 2016. Disturbed endometrial NF-κB expression in women with recurrent implantation failure. European Review for Medical and Pharmacological Sciences 20:5037–5040.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. 2011. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertility and Sterility 95:1048–1058.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, San Millan JL. 2007. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism 18:266–272.
   PubMed Web of Science ®Google Scholar
• Giudice LC. 2006. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Practice & Research Clinical Endocrinology & Metabolism 20:235–244.
   PubMed Web of Science ®Google Scholar
• González F, Minium J, Rote NS, Kirwan JP. 2005. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 90:5336–5342.
   PubMed Web of Science ®Google Scholar
• González F, Rote NS, Minium J, Kirwan JP. 2006. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 91:1508–1512.
   PubMed Web of Science ®Google Scholar
• González F, Sia CL, Shepard MK, Rote NS, Minium J. 2012. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism 97:4071–4079.
   PubMed Web of Science ®Google Scholar
• Gregory CW, Wilson EM, Apparao KB, Lininger RA, Meyer WR, Kowalik A, et al. 2002. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. The Journal of Clinical Endocrinology & Metabolism 87:2960–2966.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Baltimore D. 2006. Circuitry of nuclear factor kappaB signaling. Immunological Reviews 210:171–186.
   PubMed Web of Science ®Google Scholar
• Karin M, Yamamoto Y, Wang QM. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews Drug Discovery 3:17–26.
   PubMed Web of Science ®Google Scholar
• King AE, Critchley H, Kelly RW. 2001. The NF-kappaB pathway in human endometrium and first trimester decidua. Molecular Human Reproduction 7:175–183.
   PubMed Web of Science ®Google Scholar
• Kowalski AA, Vale-Cruz DS, Simmen FA, Simmen RC. 2004. Uterine androgen receptors: roles in estrogen-mediated gene expressionand DNA synthesis. Biology of Reproduction 70:1349–1357.
   PubMed Web of Science ®Google Scholar
• Laird SM, Tuckerman EM, Cork BA, Li TC. 2000. Expression of nuclear factor k B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Molecular Human Reproduction 6:34–40.
   PubMed Web of Science ®Google Scholar
• Lessey BA. 1994. The use of integrins for the assessment of uterine receptivity. Fertility and Sterility 61:812–814.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419.
   PubMed Web of Science ®Google Scholar
• Marsden PJ, Murdoch AP, Taylor R. 2001. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clinical Endocrinology 55:191–199.
   PubMed Web of Science ®Google Scholar
• Noyes RW, Hertig AT, Rock J. 1950. Dating the endometrial biopsy. Fertility and Sterility 1:3–25.
   Web of Science ®Google Scholar
• Ordi J, Creus M, Ferrer B, Fa´bregues F, Carmona F, Casamitjana R, et al. 2002. Midluteal endometrial biopsy and alphavbeta3 integrin expression in the evaluation of the endometrium in infertility: implications for fecundity. International Journal of Gynecological Pathology 21:231–238.
   PubMed Web of Science ®Google Scholar
• Papalou O, Livadas S, Karachalios A, Tolia N, Kokkoris P, Tripolitakis K, et al. 2015. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia. Hormones (Athens) 14:91–100.
   PubMedGoogle Scholar
• Piltonen TT, Chen J, Erikson DW, Spitzer TL, Barragan F, Rabban JT, et al. 2013. Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. The Journal of Clinical Endocrinology & Metabolism 98:3765–3775.
   PubMed Web of Science ®Google Scholar
• Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B. 2005. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. The Journal of Clinical Endocrinology & Metabolism 90:6014–6021.
   PubMed Web of Science ®Google Scholar
• Renard P, Raes M. 1999. The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell Biology and Toxicology 15:341–344.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. 2004. Fertility and Sterility 81:19–25.
   PubMed Web of Science ®Google Scholar
• Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, et al. 1988. Recurrent early miscarriage and polycystic ovaries. TheBMJ 297:1027–1028.
   Google Scholar
• Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, et al. 2011. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. The Journal of Clinical Endocrinology & Metabolism 96:1737–1746.
   PubMed Web of Science ®Google Scholar
• Sirmans SM, Weidman-Evans E, Everton V, Thompson D. 2012. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications. Annals of Pharmacotherapy 46:403–418.
   PubMed Web of Science ®Google Scholar
• Tan BK, Adya R, Chen J, Farhatullah S, Heutling D, Mitchell D, et al. 2009. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovascular Research 83:566–574.
   PubMed Web of Science ®Google Scholar
• Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, et al. 2009. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Human Reproduction Update 15:297–307.
   PubMed Web of Science ®Google Scholar
• Tulppala M, Stenman UH, Cacciatore B, Ylikorkala O. 1993. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. BJOG: An International Journal of Obstetrics & Gynaecology 100:348–352.
   Web of Science ®Google Scholar
• Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS. 2009. Inflammation in reproductive disorders. Reproductive Sciences 16:216–229.
   PubMed Web of Science ®Google Scholar
• WHO. 1995. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Consultation. WHO Technical Report Series Number 854. Geneva: World Health Organization.
   Google Scholar